Core Viewpoint - The article highlights the efforts of the Shanxi Province's Yuncheng City Xinjiang County Market Supervision Bureau to prevent the misuse of special drugs, particularly narcotic and psychotropic substances, through a comprehensive inspection of medical institutions [1] Group 1: Inspection Focus - The special inspection primarily targets medical institutions, focusing on the entire process of procurement, storage, usage, sales, and traceability of narcotic and psychotropic drugs [1] - Key management practices, referred to as the "Five Special" management system, are being verified, which includes dedicated personnel, locked cabinets, specialized account books, exclusive prescriptions, and specific registration [1] Group 2: Compliance and Verification - The inspection emphasizes the execution of security measures such as cabinet security, dual-lock systems, and the uploading of traceability codes [1] - Verification of supplier qualifications, authenticity of purchase invoices, and completeness of sales records are critical components of the inspection process [1] Group 3: Future Actions - The Xinjiang County Market Supervision Bureau plans to conduct regular follow-up inspections to address weak regulatory areas concerning special drugs [1] - There will be a combination of inspections and educational efforts aimed at enhancing the legal and responsibility awareness of industry personnel to prevent the illegal flow of special drugs [1]

Core Viewpoint - The Anhui Provincial Drug Administration has issued a negative list for administrative inspections in the pharmaceutical sector, aiming to prevent irregular law enforcement and clarify 13 prohibitive regulations regarding 44 types of inspection behaviors, thereby optimizing the business environment and supporting high-quality development in the pharmaceutical industry [1][2]. Group 1: Inspection Process - The negative list emphasizes strict control over the initiation of inspections, prohibiting unauthorized personnel from conducting inspections independently and preventing inspections beyond legal authority [1]. - It outlines that inspections must be conducted according to established procedures, including the requirement to present credentials and inform companies of their rights prior to inspections [1]. - The list also prohibits the use of inappropriate language or aggressive behavior during inspections, as well as selective enforcement and differential treatment of entities [1]. Group 2: Discipline and Responsibility - The regulations stress the importance of integrity and confidentiality, forbidding the misuse of inspection authority for personal gain, such as accepting bribes or imposing fees on companies [1]. - It mandates that inspectors must not disclose state secrets, commercial secrets, or personal privacy information acquired during their duties, thereby reinforcing dual responsibilities for integrity and confidentiality [1].

Core Viewpoint - The Anhui Provincial Drug Administration has been recognized by the National Medical Products Administration for its outstanding performance in drug vigilance work in 2025, marking the third time it has received such acknowledgment [1]. Group 1: Drug Vigilance Work - The Anhui Provincial Drug Administration has implemented comprehensive measures to enhance the drug vigilance system, including clearer regulatory guidelines and internal audit guidelines for drug license holders [2]. - The coverage rate of drug vigilance inspections in the region exceeds 40%, with a focus on addressing common deficiencies found during inspections [2]. - The establishment of adverse drug reaction monitoring points has improved risk monitoring and response measures, including timely communication and production suspension when necessary [2]. Group 2: Training and Capacity Building - The provincial drug administration has organized online training for drug vigilance inspectors and conducted competitions to foster a competitive learning environment, significantly enhancing the capabilities of regulatory personnel [2]. Group 3: Future Directions - The Anhui Provincial Drug Administration plans to continue implementing the National Medical Products Administration's requirements for drug vigilance, aiming to improve risk prevention accuracy and regulatory efficiency with stricter standards and practical measures [3].

Core Viewpoint - The meeting focused on enhancing drug safety regulation in Zhuzhou City, Hunan Province, emphasizing the need for innovation in regulatory practices and collaboration among various departments to address current challenges in drug safety [1][2]. Group 1: Meeting Outcomes - The meeting involved a review of the achievements and shortcomings of drug regulation in 2025, identifying key challenges and discussing strategies for 2026 [1]. - Participants exchanged ideas on the focus areas and innovative approaches for the upcoming year, aiming to improve regulatory effectiveness and professional capacity [1]. Group 2: Action Plan - Relevant departments are tasked with developing a comprehensive drug regulation work plan for 2026, ensuring clear objectives and actionable measures [2]. - The meeting underscored the importance of adhering to the directives from the provincial drug regulatory authority and enhancing accountability in regulatory duties [2].

Group 1 - The core viewpoint of the articles highlights the efforts of Weifang City's Market Supervision Administration in Shandong Province to enhance drug safety governance and regulatory efficiency through innovative monitoring models and risk management strategies [1][2]. Group 2 - A comprehensive risk prevention system has been established, including a collaborative risk consultation mechanism at provincial, municipal, and county levels, identifying 44 risk points in drug and medical device sectors, and implementing closed-loop management [1]. - The administration has conducted 8 expert evaluation meetings to identify 222 risk hazards and reported 35,000 adverse reaction monitoring reports, leading to the first proactive recall of a medical device by a multinational company in the province [1]. - A "clean source" action was initiated in drug distribution, resulting in 123 special case investigations and the development of eight measures to ensure quality and safety responsibilities among medical device businesses [1]. Group 3 - Collaborative efforts with health, medical insurance, public security, and education departments have led to comprehensive regulatory inspections of 170 drug and medical device units and special checks on 93 retail drug units [2]. - The administration has improved the vaccine information sharing mechanism and conducted two rounds of comprehensive inspections of vaccine usage units to ensure vaccine quality and safety [2]. Group 4 - Digital empowerment has been emphasized to enhance smart regulatory capabilities, transitioning from manual to technical defenses through the establishment of a digital regulatory archive [2]. - The Weifang City "Three Medicines" data sharing center has developed a smart regulatory system for practicing pharmacists, which is currently in trial operation to improve regulatory efficiency [2]. - The real-name registration system for narcotic and psychotropic drugs has been optimized, covering 11,000 drug operating units, enabling real-time monitoring and automatic data collection [2].

Group 1 - The core theme of the competition was "Safe Medication, Healthy Law," attracting participation from 15 provinces, 37 cities, and 261 individuals and organizations, with a total of 2017 entries submitted [1] - The competition resulted in 158 award-winning works and 21 outstanding organizing units, marking a historical high in scale, participation, and quality of entries [1] - Zhaoqing City won 8 honors, including 4 awards for second and third places, as well as the Best Creative Presentation Award, showcasing the city's strong capabilities in pharmaceutical science popularization [1][2] Group 2 - Four notable works from Zhaoqing City received recognition, including "The Red Boy's Sunscreen Allergy Story," which creatively illustrated the importance of avoiding counterfeit products and won a second prize [2] - The work "Drug Safety Code at a Glance" utilized a dance format to effectively educate on drug traceability codes, earning both a second prize and the Best Creative Presentation Award [2] - The original animated song "Grandparents' Medication Song" and the creative piece "Drug Review" also received third prizes, highlighting the innovative approaches to pharmaceutical education [2] Group 3 - The Zhaoqing Market Supervision Administration plans to leverage the competition's success to enhance the quality of science popularization efforts and will promote the award-winning works through online and offline channels [3] - The initiative aims to make professional pharmaceutical safety knowledge more accessible to the public, addressing the "last mile" of health knowledge dissemination [3]

Group 1 - The article focuses on the new dynamics, initiatives, and achievements of drug regulatory departments in China, aiming to create a platform for experience exchange and showcase results across the national drug supervision landscape [1] - It emphasizes the importance of regulatory measures in promoting the development of the pharmaceutical industry, encouraging submissions that detail successful practices and outcomes [5] - The article outlines the need for clear and structured submissions, with a word count requirement of 2000-2500 words for detailed descriptions of regulatory practices [3][7] Group 2 - The article calls for contributions that highlight the enforcement of quality and safety responsibilities by drug regulatory departments, detailing specific practices and their effectiveness [5] - It encourages the selection of distinctive practices and the inclusion of concrete examples to illustrate implementation and results [6] - The submission guidelines also specify a word count of 2000-2500 words for these contributions [7] Group 3 - The article invites exploratory articles addressing challenges and hot topics in drug regulation, focusing on specific areas to analyze current situations, identify issues, and propose suggestions for enhancing regulatory effectiveness [9] - It requires submissions to be clear and in-depth, with a word count of 1500-2500 words [10] Group 4 - The article includes a section for photo news that showcases the dynamics of drug regulatory work, including safety supervision, industry support, and public awareness activities [11] - It specifies that photos should be at least 1MB in size and must feature clear themes and clean visuals [12] Group 5 - The call for submissions is ongoing, with specific instructions regarding the use of AI tools in the writing process and the requirement to indicate the submission category in the email title [13]

Core Insights - The article discusses a training organized by the Pingchuan District Market Supervision Administration aimed at enhancing the regulation of drug operations in response to new business models and challenges in the industry [1][3]. Group 1: Training Objectives and Content - The training focuses on the requirements of various laws and regulations, including the Drug Administration Law of the People's Republic of China and the Drug Network Sales Supervision Management Measures [3]. - It covers key regulatory aspects of the entire drug operation chain, including procurement, acceptance, storage, and personnel management [3]. - The training emphasizes the importance of establishing a warning mechanism for near-expiry drugs and clarifies the responsibilities of enterprises and regulatory personnel [3]. Group 2: Regulatory Focus and Implementation - The training aims to refine regulatory points and analyze typical cases to standardize the drug operation regulatory process [3]. - It highlights the identification of violations such as false advertising and exaggerated efficacy in new business models like e-commerce and live streaming [3]. - The initiative is expected to enhance the professionalism and standardization of drug regulation work, thereby strengthening the safety of drug use for the community [3].

Group 1 - The core viewpoint of the news is the issuance of four administrative discretion benchmarks in Inner Mongolia aimed at standardizing regulatory practices for "two drugs and one device" [1][2] - The benchmarks include the Administrative Licensing Discretion Benchmark, which covers 26 main administrative licensing items and 66 sub-items related to drug production, medical institution preparation licenses, and cosmetic production licenses [1] - The Administrative Inspection Discretion Benchmark outlines 15 administrative inspection items, including daily inspections of drug production, with clear guidelines on purpose, scope, principles, and responsibilities [2] Group 2 - The Administrative Coercive Discretion Benchmark specifies 12 administrative coercive measures, detailing the implementation, extension, and termination conditions for each measure [2] - The Administrative Reward Discretion Benchmark provides specific criteria and operational standards for administrative rewards, including 10 key aspects such as basis for setting rewards and implementation levels [2]

Group 1: National Water Network Construction - The meeting highlighted the progress in the construction of the national water network, emphasizing its role in optimizing water resource allocation, enhancing flood prevention and disaster reduction capabilities, and ensuring national water security [1] - The construction of the national water network is seen as a strategic measure with multiple benefits, including transportation, ecological protection, and tourism, serving as a key driver for expanding domestic demand [1] - The meeting called for innovative investment and financing mechanisms, encouraging state-owned enterprises to increase investment and attract private capital for multi-channel funding of construction projects [1] Group 2: Cross-Border Trade Facilitation - Cross-border trade facilitation is identified as a crucial element in creating a first-class business environment, with a focus on enhancing efficient logistics and multi-modal transport coordination [2] - The meeting emphasized the development of new business models such as green trade and cross-border e-commerce, along with optimizing the regulation of special goods [2] - There is a push for improving smart regulatory services and strengthening quality control of import and export goods to ensure efficient and effective trade management [2] Group 3: Drug Management Regulations - The meeting underscored the importance of timely revisions to drug management laws and regulations in response to changing circumstances, which is vital for ensuring public safety in medication and promoting a healthy pharmaceutical industry [3] - There is a focus on improving drug research and registration systems, expediting the review and approval of breakthrough therapies to stimulate industry innovation [3] - The meeting called for maintaining a stringent regulatory environment, enhancing quality supervision across the entire drug supply chain, and cracking down on illegal activities in the pharmaceutical sector [3]